After traveling with Medifast's management, DA Davidson analyst Linda Bolton Weiser is more confident in the company's growth outlook. She thinks that its decision to double the number of health coaches it uses in the next 24-30 months will boost its operating margins, and says that its decision to launch operations overseas "could drive 10 years of strong growth." The analyst believes that the company " can deliver double-digit top- and bottom-line growth for the foreseeable future." She raised her price target on the stock to $74 from $65 and keeps a Buy rating on the shares.